Follow Us

header ads
header ads

Vascular Grafts Market Rising at a Steady CAGR of 5.24% by 2030

The global vascular grafts market size is expected to reach around US$ 8.5 billion by 2030 and is expected to grow at an impressive double-digit rate of 5.24% from 2022 to 2030.

The vascular graft market shows a tremendous growth owing to the increase in the number of minimally invasive procedures carried out by the technically advanced hospitals and healthcare systems.

Vascular Grafts Market Size 2021 to 2030

The study includes drivers and restraints of this market. The study provides an analysis of the global vascular grafts market for the period 2017-2030, wherein 2022 to 2030 is the forecast period and 2021 is considered as the base year.

Report Scope of the Vascular Grafts Market

Report CoverageDetails
Market Size by 2030USD 8.5 Billion
Growth Rate from 2022 to 2030

CAGR of 5.24%

North America Market Share in 202131% 
Endovascular Stent Grafts Market Share in 202164%
Base Year2021
Forecast Period2022 to 2030

Our Free Sample Reports Includes:

  • In-depth Industry Analysis, Introduction, Overview, and COVID-19 Pandemic Outbreak.
  • Impact Analysis 150+ Pages Research Report (Including latest research).
  • Provide chapter-wise guidance on request 2022 Updated Regional Analysis with Graphical Representation of Trends, Size, & Share, Includes Updated List of figures and tables.
  • Updated Report Includes Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis by using Precedence Research methodology.

Download Free Sample Copy Here (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1758

Research Methodology

A unique research methodology has been utilized to conduct comprehensive research on the growth of the global vascular grafts market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the draw conclusions. Secondary sources referred to by analysts during the production of the global market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.

These primary and secondary sources provided exclusive information during interviews, which serves as a validation from mattress topper industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global vascular grafts market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped to estimates the future prospects of the global market more reliable and accurate.

Why should you invest in this report?

If you are aiming to enter the global vascular grafts market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for vascular grafts are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030, so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Some of the prominent players in the global vascular grafts market include:

  • Getinge AB
  • Medtronic PLC
  • LeMaitre vascular Inc
  • WL gore and associates
  • terumo corporation
  • Shanghai suokang medical implants Co limited
  • Cook medical

Market Segmentation:

By Product

  • Vascular Grafts for Aorta Disease
  • Peripheral Vascular Grafts
  • Endovascular Stent Grafts
  • Coronary Artery By-Pass Grafts

By Application

  • Cardiac Aneurysm
  • Kidney Failure
  • Vascular Occlusion
  • Coronary Artery Disease

By Raw Material

  • Polyester Vascular Grafts
  • Polytetrafluoroethylene Vascular Grafts
  • Polyurethane Vascular Grafts
  • Biological Material Based Vascular Grafts
    • Human Saphenous and Umbilical Veins
    • Tissue Engineered Materials

By End User

  • Hospitals
  • Ambulatory Surgical Centers

Regional Analysis:

The geographical analysis of the global vascular grafts market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.

The North American Market is again segmented into the US, Canada, and Mexico. Coming to the European Market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global vascular grafts Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).

Key Questions Answered by the Report:

  • What will be the size of the global vascular grafts market in 2030?
  • What is the expected CAGR for the vascular grafts market between 2021 and 2030?
  • Which are the top players active in this global market?
  • What are the key drivers of this global market?
  • How will the market situation change in the coming years?
  • Which region held the highest market share in this global market?
  • What are the common business tactics adopted by players?
  • What is the growth outlook of the global vascular grafts market?

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Vascular Grafts Market 

5.1. COVID-19 Landscape: Vascular Grafts Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Vascular Grafts Market, By Product

8.1. Vascular Grafts Market, by Product Type, 2022-2030

8.1.1. Vascular Grafts for Aorta Disease

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Peripheral Vascular Grafts 

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Endovascular Stent Grafts

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Coronary Artery By-Pass Grafts

8.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Vascular Grafts Market, By End Use

9.1. Vascular Grafts Market, by End Use, 2022-2030

9.1.1. Hospitals

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Ambulatory Surgical Centers

9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Vascular Grafts Market, By Application Type 

10.1. Vascular Grafts Market, by Application Type, 2022-2030

10.1.1. Cardiac Aneurysm

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Kidney Failure

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Vascular Occlusion

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Coronary Artery Disease

10.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Vascular Grafts Market, By Raw Material Type 

11.1. Vascular Grafts Market, by Raw Material Type, 2022-2030

11.1.1. Polyester Vascular Grafts

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Polytetrafluoroethylene Vascular Grafts

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Polyurethane Vascular Grafts

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Biological Material Based Vascular Grafts

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Human Saphenous and Umbilical Veins

11.1.5.1. Market Revenue and Forecast (2017-2030)

11.1.6. Tissue Engineered Materials

11.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Vascular Grafts Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.2. Market Revenue and Forecast, by End Use (2017-2030)

12.1.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.1.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.5.2. Market Revenue and Forecast, by End Use (2017-2030)

12.1.5.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.1.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.6.2. Market Revenue and Forecast, by End Use (2017-2030)

12.1.6.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.1.6.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.2. Market Revenue and Forecast, by End Use (2017-2030)

12.2.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.2.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.5.2. Market Revenue and Forecast, by End Use (2017-2030)

12.2.5.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.2.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.6.2. Market Revenue and Forecast, by End Use (2017-2030)

12.2.6.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.2.6.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.7.2. Market Revenue and Forecast, by End Use (2017-2030)

12.2.7.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.2.7.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.8.2. Market Revenue and Forecast, by End Use (2017-2030)

12.2.8.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.2.8.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.2. Market Revenue and Forecast, by End Use (2017-2030)

12.3.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.3.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.5.2. Market Revenue and Forecast, by End Use (2017-2030)

12.3.5.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.3.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.6.2. Market Revenue and Forecast, by End Use (2017-2030)

12.3.6.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.3.6.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.7.2. Market Revenue and Forecast, by End Use (2017-2030)

12.3.7.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.3.7.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.8.2. Market Revenue and Forecast, by End Use (2017-2030)

12.3.8.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.3.8.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.2. Market Revenue and Forecast, by End Use (2017-2030)

12.4.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.4.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.5.2. Market Revenue and Forecast, by End Use (2017-2030)

12.4.5.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.4.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.6.2. Market Revenue and Forecast, by End Use (2017-2030)

12.4.6.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.4.6.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.7.2. Market Revenue and Forecast, by End Use (2017-2030)

12.4.7.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.4.7.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.8.2. Market Revenue and Forecast, by End Use (2017-2030)

12.4.8.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.4.8.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.2. Market Revenue and Forecast, by End Use (2017-2030)

12.5.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.5.2. Market Revenue and Forecast, by End Use (2017-2030)

12.5.5.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.5.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.6.2. Market Revenue and Forecast, by End Use (2017-2030)

12.5.6.3. Market Revenue and Forecast, by Application Type (2017-2030)

12.5.6.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)

Chapter 13. Company Profiles

13.1. Getinge AB

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Medtronic PLC

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. LeMaitre vascular Inc

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. WL gore and associates

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. terumo corporation

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Shanghai suokang medical implants Co limited

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Cook Medical

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Post a Comment

0 Comments